ADMET Translating Research into Clinical Outcomes, 7 – 8 July 2010

Crowne Plaza St. James Hotel
45-51 Buckingham Gate
LONDON
SW1E 6AF

Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) screening is crucial to the drug development process and assists the elimination rate of weak drug candidates early in the drug-discovery process, and decreases the proportion of compounds failing in clinical trials for ADMET reasons. SMi’s 5th Annual ADMET Conference will bring you up to date with the latest developments, technologies and techniques that are in use across the industry and look towards the future.

This meeting will feature talks from experts who will address topics including:

ADMET and PK/PD modelling in drug discovery and development
Innovative ADME models
ADME optimisation in early- and late-phase drug discovery
Drug-drug interaction prediction
Drug transporter assays
Predictive toxicology model development
Emerging in vitro and in vivo toxicity assays
Metabolism based toxicity

For further information please see the website:

http://www.smi-online.co.uk/events/overview.asp?is=4&ref=3261

ADMET Translating Research into Clinical Outcomes, 7 – 8 July 2010

Privacy Overview

Strictly Necessary Cookies

3rd Party Cookies